3rd Quarter - Report
W STRATEGIES, LLC for ALEXION PHARMACEUTICALS
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
21st Century Cures 2.0. FY 22 Budget Reconciliation as it relates to H.R.3: Elijah E. Cummings Lower Drug Costs Now Act, H.R.19: Lower Costs, More Cures Act of 2021 and the Orphan Drug Tax Credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.